Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Tye

Showing results (61-70 of 150) with videos related to

Pageof 15
Sort By:
Neuroscience and Biobehavioral Reviews|May 15, 2018
A review of brain insulin signaling in mood disorders: From biomarker to clinical targetThanh Thanh L Nguyen, Lily C Chan, Kristin Borreginne, et al.
Behavioural Brain Research|March 10, 2016
Antidepressant actions of lateral habenula deep brain stimulation differentially correlate with CaMKII/GSK3/AMPK signaling locally and in the infralimbic cortexYesul Kim, Brooke Morath, Chunling Hu, et al.
Journal of Affective Disorders|April 16, 2022
Neurocognitive effects of repeated ketamine infusions in comorbid posttraumatic stress disorder and major depressive disorderC Sophia Albott, Kelvin O Lim, Christopher Erbes, et al.
Biological Psychiatry|January 27, 2023
Ketamine-Associated Change in Anhedonia and mTOR Expression in Treatment-Resistant DepressionBalwinder Singh, Jennifer L Vande Voort, Patricio Riva-Posse, et al.
Psychopharmacology|April 28, 2016
Behavioral and qEEG effects of the PDE10A inhibitor THPP-1 in a novel rhesus model of antipsychotic activityJoshua D Vardigan, Henry S Lange, Spencer J Tye, et al.
Behavioural Brain Research|July 26, 2015
Peripheral proinflammatory markers associated with ketamine response in a preclinical model of antidepressant-resistanceAdam J Walker, Brittany M Foley, Shari L Sutor, et al.
Depression and Anxiety|April 11, 2016
KETAMINE FOR TREATMENT-RESISTANT UNIPOLAR AND BIPOLAR MAJOR DEPRESSION: CRITICAL REVIEW AND IMPLICATIONS FOR CLINICAL PRACTICEWilliam V Bobo, Jennifer L Vande Voort, Paul E Croarkin, et al.
Cancer Immunology, Immunotherapy : CII|March 14, 2009
Human CD80/IL2 lentivirus transduced acute myeloid leukaemia cells enhance cytolytic activity in vitro in spite of an increase in regulatory CD4+ T cells in a subset of culturesWendy Ingram, Shahram Kordasti, Lucas Chan, et al.
Frontiers in Psychiatry|May 1, 2014
Stress, Inflammation, and Cellular Vulnerability during Early Stages of Affective Disorders: Biomarker Strategies and Opportunities for Prevention and InterventionAdam J Walker, Yesul Kim, J Blair Price, et al.
The Journal of Biological Chemistry|March 30, 2001
The human gC1qR/p32 gene, C1qBP. Genomic organization and promoter analysisA J Tye, B Ghebrehiwet, N Guo, et al.
Pageof 15

Showing results (61-70 of 150) with videos related to

Sort By:
Pageof 15
Neuroscience and Biobehavioral Reviews|May 15, 2018
A review of brain insulin signaling in mood disorders: From biomarker to clinical targetThanh Thanh L Nguyen, Lily C Chan, Kristin Borreginne, et al.
Behavioural Brain Research|March 10, 2016
Antidepressant actions of lateral habenula deep brain stimulation differentially correlate with CaMKII/GSK3/AMPK signaling locally and in the infralimbic cortexYesul Kim, Brooke Morath, Chunling Hu, et al.
Journal of Affective Disorders|April 16, 2022
Neurocognitive effects of repeated ketamine infusions in comorbid posttraumatic stress disorder and major depressive disorderC Sophia Albott, Kelvin O Lim, Christopher Erbes, et al.
Biological Psychiatry|January 27, 2023
Ketamine-Associated Change in Anhedonia and mTOR Expression in Treatment-Resistant DepressionBalwinder Singh, Jennifer L Vande Voort, Patricio Riva-Posse, et al.
Psychopharmacology|April 28, 2016
Behavioral and qEEG effects of the PDE10A inhibitor THPP-1 in a novel rhesus model of antipsychotic activityJoshua D Vardigan, Henry S Lange, Spencer J Tye, et al.
Behavioural Brain Research|July 26, 2015
Peripheral proinflammatory markers associated with ketamine response in a preclinical model of antidepressant-resistanceAdam J Walker, Brittany M Foley, Shari L Sutor, et al.
Depression and Anxiety|April 11, 2016
KETAMINE FOR TREATMENT-RESISTANT UNIPOLAR AND BIPOLAR MAJOR DEPRESSION: CRITICAL REVIEW AND IMPLICATIONS FOR CLINICAL PRACTICEWilliam V Bobo, Jennifer L Vande Voort, Paul E Croarkin, et al.
Cancer Immunology, Immunotherapy : CII|March 14, 2009
Human CD80/IL2 lentivirus transduced acute myeloid leukaemia cells enhance cytolytic activity in vitro in spite of an increase in regulatory CD4+ T cells in a subset of culturesWendy Ingram, Shahram Kordasti, Lucas Chan, et al.
Frontiers in Psychiatry|May 1, 2014
Stress, Inflammation, and Cellular Vulnerability during Early Stages of Affective Disorders: Biomarker Strategies and Opportunities for Prevention and InterventionAdam J Walker, Yesul Kim, J Blair Price, et al.
The Journal of Biological Chemistry|March 30, 2001
The human gC1qR/p32 gene, C1qBP. Genomic organization and promoter analysisA J Tye, B Ghebrehiwet, N Guo, et al.
Pageof 15